Strong Medicare Star Ratings reinforce Asuris Northwest

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
86
Strong Medicare Star Ratings reinforce Asuris Northwest Health’s commitment to excellence for its members

Spokane, WA, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Asuris Northwest Health earned strong ratings in quality and performance from the Centers for Medicare & Medicaid Services (CMS) for its 2018 Medicare Advantage health plan.

CMS Star Ratings * are a measure of health plan quality. The program’s goal is to improve health outcomes and patient experience, and reduce costs for members. These ratings work to help consumers make educated choices when selecting a high-quality Medicare health plan. CMS publishes the ratings annually on a scale from 1 to 5 to help Medicare beneficiaries choose from the best plans. For 2018, Asuris’ Medicare Advantage PPO plan earned 4 stars.

“Our teams work year-round to ensure we provide members with the best possible health care experience,” said Kathleen Faulk, Asuris’ general manager of government programs. “Maintaining health plans with 4 Stars or higher reflects our commitment to excellence—behind the data and metrics are real people who count on us to provide exceptional health care coverage, value and support.”

Specific health measures where Asuris performed well include medication therapy management (MTM) / comprehensive medication review (CMR), call center support, complaints, member perception of ease of access to care with in-network providers, and PPO members choosing to stay with their Asuris health plan.

“It takes an incredible amount of work, collaboration and focus to achieve 4 stars or higher—fortunately we have the right talent and leadership in place,” said Scott Powers, Asuris’ president of health plan operations. “Health plans that don’t improve year-over-year risk lower ratings. We must continue to invest resources to support member health and well-being, operationally and programmatically across all plans.”

Turning toward 2018 and beyond, Asuris will continue building on its health plan’s strengths as well as make further improvements to drive member health outcomes. “Our Medicare Advantage members represent the most vulnerable populations we serve,” added Faulk. “We take our role very seriously and will continue to deliver valuable health coverage and support today and far into the future.”

*Medicare evaluates plans based on a 5-star rating system. Star Ratings are calculated each year and may change from one year to the next.

About Asuris Northwest Health

Asuris Northwest Health offers a full range of health care coverage options, including dental coverage, for eastern Washington employers and individuals. We also offer Medicare supplemental plans and Medicare Part D prescription drug coverage, and provide member access to more than 20,000 health care providers. Asuris is committed to improving the health of our members and our communities, and to transforming our health care system. Asuris Northwest Health, a nonprofit health plan, is a member of the Cambia Health Solutions family of companies. For more information, please visit www.asuris.com or www.twitter.com/AsurisNWHealth .

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...1d219548b7

Jennifer Morgan Asuris Northwest Health (206) 332-5083 jennifer.morgan@cambiahealth.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AB SKF to Hold EGM, Spin Off Automotive Assets

Updated Category News Views 5

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...

Continue Reading
DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Updated Category News Views 1

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...

Continue Reading
CABP Market Sees Potential in New Treatments Rising

Updated Category News Views 2

Rising Threats and New Solutions in CABP Market Listen up, folks. The community-acquired bacterial pneumonia (CABP) market is set to swell. And why is that? Well, it's got everything to do with a growing disease burden, aging populations, and complications from comorbid conditions. But here's the kicker: antimicrobial resistance is climbing like a cat up a tree, and that...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 9

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
Wooree Group Pushes for Rigorous Liposome Standards

Updated Category News Views 1

Rallying for Rigorous Scientific Validation Ever find yourself pondering how many so-called 'innovative' health products really deliver what they promise? Let me tell ya, Wooree Group’s CEO, Ji-yong Yoon, ain’t buying into flimsy claims. At the Vitafoods Asia 2026 event in Bangkok, Yoon sent a clear message: Without scientific validation, calling a product 'liposomal'...

Continue Reading
Interventional Ophthalmology: Early Eye Care Strategies Evolve

Updated Category News Views 2

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Continue Reading
Dentsply Sirona Faces Insider Troubles: An Investor Call

Updated Category News Views 3

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Continue Reading
SKF's Automotive Arm Set for Stockholm Debut in Dec

Updated Category News Views 4

The Big Spin-Off Play: SKF Vertevo So, SKF is at it again, pushing their Automotive business out the door as a newly minted public company—SKF Vertevo—on the horizon. It's like watching a mother bird kick the fledgling out of the nest. The Board's cooked up this spin-off strategy, and they're eyeing the Nasdaq Stockholm as the breeding ground, with the gears all set...

Continue Reading
Huayan Robotics Hits IMTS 2026 with Cutting-Edge Tech

Updated Category News Views 2

Unveiling Robotics Prowess at IMTS 2026 Every two years, the world of manufacturing gathers at the International Manufacturing Technology Show (IMTS), and this time, the spotlight is on Huayan Robotics. With the event drawing over 90,000 professionals, everybody with a finger on the pulse of intelligent manufacturing will be keen to see what Huayan has up its sleeve. This...

Continue Reading
Stem Cell Market Set for Major Gains to 2031

Updated Category News Views 1

Stem Cells: The Next Frontier or Hype? Folks, stem cells are no longer just a sci-fi concept tucked away in lab coats. This sector's set to boom from USD 18.9 billion in 2026 to a whopping USD 32.57 billion by 2031. Yeah, you heard it right, a solid 11.5% compound annual growth rate. Now, whether you're an investor or just keeping your finger on the biotech pulse, there's...

Continue Reading

Top 5 Most Recently Viewed Articles

Joey Bosa's $12.6M Deal and His Future Beyond the NFL

Updated Category News Views 484

Joey Bosa: A Star on the Field and in Business Joey Bosa is making headlines not just for his performance on the football field but also for his impressive off-field ventures. With the announcement of a new contract, he is poised for a thrilling season ahead. A New Chapter with the Buffalo Bills Recently, Bosa secured a lucrative one-year deal valued at $12.6 million with...

Continue Reading
Tesla's Vision for the Future of Autonomous Transportation

Updated Category News Views 259

The Exciting Future of Tesla's Autonomous Vehicles The recent unveiling by Tesla has stirred excitement and curiosity among both fans and investors. At a vibrant event, Elon Musk showcased Tesla's ambitious vision for the future of transportation with the introduction of their long-anticipated driverless robotaxis. This presentation had every characteristic of Musk's...

Continue Reading
Ask Hercules: New Tool Boosts AI Visibility for SMBs

Updated Category News Views 19

AI Visibility: The New Frontier for SMBs There's a new name in town aiming to make sure small and midsize businesses aren't left in the dust of the AI revolution. Muse Platforms just launched Ask Hercules, an AI visibility platform that gives businesses, creators, and thought leaders a chance to assess and improve how they show up on AI platforms like ChatGPT, Claude, and...

Continue Reading
Transforming $100 into $343: A Look at ServiceNow's Growth

Updated Category News Views 68

How a $100 Investment in ServiceNow Could Transform Your Finances ServiceNow (NYSE: NOW) has shown remarkable performance in the stock market over the past five years, demonstrating an annualized return of 27.51%. Impressively, this places its overall growth at 13.52% above market averages. The Current Market Capitalization As it stands, ServiceNow boasts a substantial...

Continue Reading
Gladstone Land Faces Market Challenges as Stock Reaches Low

Updated Category News Views 426

Market Challenges for Gladstone Land Corporation In a rapidly evolving economic landscape, Gladstone Land Corporation (NASDAQ: LAND) has recently encountered hurdles as its stock dipped to a 52-week low, reaching a price of $10.44. This decline highlights the stock's turbulent journey over the past year, where it has decreased by approximately 27.82%. With a market...

Continue Reading